Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics

Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics

September 8, 2026Posted inBiotechnology

Schrödinger announced the launch of new immune disease-focused Tectora Therapeutics, which comes online with a $55 million series A financing round.

Post navigation

Previous Post
mutant-tp53-traps-foxp3,-disrupting-pd-l1-control-and-fueling-immune-evasion-in-lung-cancer Mutant TP53 traps FOXP3, disrupting PD-L1 control and fueling immune evasion in lung cancer
Next Post
Anticancer Candidate Strengthens Bones and Prevents Weight Gain in Postmenopausal Mice

Recent Posts

  • Deep Learning Outperforms Classical Algorithms in Benchmark for Cancer Histopathology Segmentation
  • Standardized Breast Cancer Mortality Among Chinese Women Declined Gradually Through 2021
  • Blood Cancer United Launches Real-World Evidence Initiative for Pediatric Acute Myeloid Leukemia
  • Inline HPLC Detects Radioactive Daughters in Actinium Radiopharmaceuticals
  • Study Assesses Behavioral Patterns And Design Quality On Karaj Urban Street

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top